These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21543293)

  • 41. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.
    Redón J; Pascual-Izuel JM; Rodilla E; Vicente A; Oliván J; Bonet J; Torguet JP; Calaforra O; Almirall J
    Blood Press; 2014 Jun; 23(3):181-8. PubMed ID: 24059690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to moderate hypertension.
    Weiss RJ; Weber MA; Carr AA; Sullivan WA
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):667-76. PubMed ID: 17786067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
    Weber MA; Bakris GL; Tarka EA; Iyengar M; Fleck R; Sica DA
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12):840-9. PubMed ID: 17170609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure.
    Eeftinck Schattenkerk DW; van den Bogaard B; Cammenga M; Westerhof BE; Stroes ES; van den Born BJ
    J Hypertens; 2013 Dec; 31(12):2447-54. PubMed ID: 24126713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of Beta-blockers as first-line therapy in hypertension.
    De Caterina AR; Leone AM
    Curr Atheroscler Rep; 2011 Apr; 13(2):147-53. PubMed ID: 21207202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pulse pressure, arterial compliance and Buckberg index in hypertensive patients treated with nebivolol and nitrates].
    Prisadă OV; Covic A; Arghiri E; Cernomaz A; Ungureanu G
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):352-7. PubMed ID: 17983167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carvedilol and atenolol once daily in the treatment of hypertension.
    Luurila OJ; Härkönen R; Hilden M; Icen R; Kohvakka A; Linna M; Sillanpää J; Vänskä O; Lukkala K
    J Hypertens Suppl; 1989 Dec; 7(6):S264-5. PubMed ID: 2576666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients.
    Acelajado MC; Pisoni R; Dudenbostel T; Oparil S; Calhoun DA; Glasser SP
    J Am Soc Hypertens; 2012; 6(1):66-72. PubMed ID: 22024668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carvedilol in the treatment of mild to moderate hypertension: experience with ambulatory blood pressure monitoring.
    Biston P; Van de Borne P; Mélot C; Smekens P; Marinus W; Degaute JP
    Acta Cardiol; 1994; 49(2):145-55. PubMed ID: 8053282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antihypertensive effect of carvedilol: a preliminary dose-response study.
    Casadei B; Conway J; Coats AJ; Bird R
    Clin Investig; 1992; 70 Suppl 1():S37-8. PubMed ID: 1350482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Etamicastat, a novel dopamine β-hydroxylase inhibitor: tolerability, pharmacokinetics, and pharmacodynamics in patients with hypertension.
    Almeida L; Nunes T; Costa R; Rocha JF; Vaz-da-Silva M; Soares-da-Silva P
    Clin Ther; 2013 Dec; 35(12):1983-96. PubMed ID: 24296323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of a single dose of 20 mg tadalafil, a phosphodiesterase 5 inhibitor, on ambulatory blood pressure in subjects with hypertension.
    Patterson D; McInnes GT; Webster J; Mitchell MM; Macdonald TM
    Br J Clin Pharmacol; 2006 Sep; 62(3):280-7. PubMed ID: 16934043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
    Marchi F; Ciriello G
    Adv Ther; 1995; 12(4):212-21. PubMed ID: 10155349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
    Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
    Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Short-term effect of nebivolol on the left ventricular diastolic function].
    Demiralp E; Kardeşoğlu E; Celik T; Cebeci BS; Ozmen N; Işilak Z; Ulusoy RE; Dinçtürk M
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):323-36. PubMed ID: 15590361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension.
    Galderisi M; D'Errico A; Sidiropulos M; Innelli P; de Divitiis O; de Simone G
    J Hypertens; 2009 Oct; 27(10):2108-15. PubMed ID: 19564794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.